Strand Therapeutics is a clinical-stage biotechnology company pioneering programmable mRNA therapeutics to unlock the full potential of genetic medicines
Strand Therapeutics is a clinical-stage biotechnology company pioneering programmable mRNA therapeutics to unlock the full potential of genetic medicines. The company focuses on overcoming foundational limitations in targeting, durability, and safety of mRNA therapies, with a pipeline that includes treatments for oncology and autoimmune diseases.